Lindsey Nondorf
Family Medicine · Shelbyville, INNPI 1114455243
Payments from drug & device makers
Across 101 payments — averaging $16.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$536
- Axsome Therapeutics, Inc.$184
- Novo Nordisk$180
- Lilly USA, LLC$114
- Boehringer Ingelheim$103
- Pfizer$100
- plus $449 from 15 others
What the payments were for
- Food & beverage$1,666100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,666 in reported general payments places this provider in the 65th percentile of 2,709 family medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 54 | $63,589 |
| EliquisApixaban | 52 | $54,217 |
| MounjaroTirzepatide | 44 | $46,642 |
| JardianceEmpagliflozin | 20 | $37,221 |
| XareltoRivaroxaban | 13 | $17,253 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $15,017 |
| LinzessLinaclotide | 12 | $12,261 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 39 | $8,722 |
| Spiriva RespimatTiotropium Bromide | 15 | $7,790 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $7,241 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 22 | $6,846 |
| Repatha SureclickEvolocumab | 11 | $6,303 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $5,608 |
| Levothyroxine Sodium | 209 | $3,419 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $3,397 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $180 | $63,58954 claims |
| PfizerEliquis | $100 | $54,21752 claims |
| Lilly USA, LLCMounjaro | $114 | $46,64244 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $103 | $45,01035 claims |
| GSKTrelegy Ellipta, Shingrix, Arexvy | $72 | $30,58480 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $30 | $12,84934 claims |
| AbbVieLinzess | $536 | $12,26112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Shelbyville
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
- Alexander Dela LlanaEvansville$1.6M
- Jonathan ConditMuncie$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.